Healthleap Raises $38M for AI Screening
Healthleap secures $38M in seed and Series A funding for its AI-driven hospital patient risk identification platform.
ImportanceLocalEvidenceE3 inspectableWrite-upQuick
Healthleap announced it has raised $38 million across two rounds: an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures.
Founded in 2022, the startup uses large language models to analyze unstructured text in electronic health records, such as clinician notes, to identify patients at risk for undiagnosed conditions like malnutrition and delirium. The platform is currently deployed in over 50 hospitals, including Penn Medicine and Cedars-Sinai.
The company did not disclose its valuation. CEO Josiah Meyer stated that revenue has grown more than 10x over the past three years and that all customers have achieved at least 5x hard ROI, though these figures are self-reported and not independently audited. The new capital will support engineering, sales, and expansion into outpatient and home care settings.